Related Experiment Video

Updated: Jun 10, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB

Kin Chung Leung1, Ming-Yue Li, Billy C S Leung

  • 1Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.

Experimental Cell Research
|July 22, 2010
PubMed

Insights

The thromboxane synthase inhibitor 1-Benzylimidazole (1-BI) triggers lung cancer cell death by increasing reactive oxygen species (ROS) and decreasing NF-κB activity. Antioxidants block this cancer cell death effect.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Thromboxane synthase (TXS) inhibition is recognized for inducing apoptosis in cancer cells.
  • The specific mechanism by which TXS inhibitor 1-Benzylimidazole (1-BI) induces apoptosis in lung cancer cells requires further elucidation.

Purpose of the Study:

  • To investigate the role of reactive oxygen species (ROS) and Nuclear Factor-kappa B (NF-κB) signaling in 1-BI-induced apoptosis in human lung cancer cells.
  • To analyze the underlying mechanisms of 1-BI's cytotoxic effects on lung cancer.

Main Methods:

  • Human lung cancer cells were treated with 1-BI.
  • Measurement of reactive oxygen species (ROS) levels.
  • Determination of NF-κB activity, including assessment of phosphorylated IκBα (p-IκBα) and p65 nuclear translocation.
  • Evaluation of antioxidant N-acetyl cysteine (NAC) effects on cell proliferation and survival.

Main Results:

  • 1-BI treatment led to increased ROS generation in lung cancer cells.
  • 1-BI significantly decreased NF-κB activity by reducing p-IκBα levels and inhibiting p65 nuclear translocation.
  • The antioxidant NAC counteracted the effects of 1-BI, promoting cell proliferation and protecting cells from 1-BI-induced death by neutralizing ROS.

Conclusions:

  • Apoptosis induced by 1-BI in lung cancer cells is closely linked to the overproduction of ROS and a concurrent reduction in NF-κB activity.
  • Antioxidant interventions can effectively mitigate the anti-cancer effects of 1-BI, highlighting the critical role of ROS in its mechanism of action.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...